ES2173425T3 - Analogos de la vitamina d - Google Patents
Analogos de la vitamina dInfo
- Publication number
- ES2173425T3 ES2173425T3 ES97910261T ES97910261T ES2173425T3 ES 2173425 T3 ES2173425 T3 ES 2173425T3 ES 97910261 T ES97910261 T ES 97910261T ES 97910261 T ES97910261 T ES 97910261T ES 2173425 T3 ES2173425 T3 ES 2173425T3
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- group
- methylene
- well
- optionally replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical group C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 abstract 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical group C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 abstract 1
- -1 HYDROXYL GROUP Chemical group 0.000 abstract 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001721 carbon Chemical class 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I) EN LA QUE X ES HIDROGENO O HIDROXI; R 1 Y R 2 , QUE PUEDEN SER IGUALES O DIFERENTES, REPRESENTAN HIDROGENO O HIDROCARBILO C 1 - C 5 ; O R 1 Y R 2 , JUNTO C ON EL ATOMO DE CARBONO QUE LLEVA EL GRUPO X, PUEDEN FORMAR UN ANILLO CARBOCICLICO C 3 - C 8 ; Q ES METILENO, ETILENO, TRI - O TETRA - METILENO Y SE PUEDE SUSTITUIR OPCIONALMENTE POR UN GRUPO OXI, - OR 3 , EN EL QUE R 3 ES HIDROGENO, METILO O ETILO; Y ES BIEN UN ENLACE SENCILLO O BIEN UN HIDROCARBILENO C 1 - C 2 ; Y UNO O MAS CARBONOS PUDIENDO SER R 1 , R 2 Y/O Y OPCIONALMENTE SUSTITUIDOS POR UNO O MAS ATOMOS DE FLUOR O POR UN GRUPO HIDROXILO. LOS COMPUESTOS PRESENTAN UNOS EFECTOS ANTIIFLAMATORIOS E INMUNOMODULADORES ASI COMO UNA FUERTE ACTIVIDAD PARA INDUCIR LA DIFERENCIACION E INHIBIR LA PROLIFERACION NO DESEADA DE CIERTAS CELULAS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9622590.9A GB9622590D0 (en) | 1996-10-30 | 1996-10-30 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2173425T3 true ES2173425T3 (es) | 2002-10-16 |
Family
ID=10802170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97910261T Expired - Lifetime ES2173425T3 (es) | 1996-10-30 | 1997-10-27 | Analogos de la vitamina d |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6310226B1 (es) |
| EP (1) | EP0937038B1 (es) |
| JP (1) | JP3907010B2 (es) |
| KR (1) | KR100526644B1 (es) |
| CN (1) | CN1107669C (es) |
| AT (1) | ATE216361T1 (es) |
| AU (1) | AU722659B2 (es) |
| CA (1) | CA2266479C (es) |
| CZ (1) | CZ290933B6 (es) |
| DE (1) | DE69712086T2 (es) |
| DK (1) | DK0937038T3 (es) |
| ES (1) | ES2173425T3 (es) |
| GB (1) | GB9622590D0 (es) |
| HK (1) | HK1022298A1 (es) |
| HU (1) | HUP9904333A3 (es) |
| NZ (1) | NZ334328A (es) |
| PL (1) | PL192660B1 (es) |
| PT (1) | PT937038E (es) |
| RO (1) | RO120338B1 (es) |
| RU (1) | RU2183622C2 (es) |
| WO (1) | WO1998018759A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2296145A1 (en) * | 1997-07-17 | 1999-01-28 | F. Hoffmann-La Roche Ag | Dihomo-seco-cholestanes with two unsaturated bonds in the side chain |
| EP1458678A1 (en) * | 2002-11-18 | 2004-09-22 | Teva Pharmaceutical Industries Limited | A crystallization method for purification of calcipotriene |
| JP4667450B2 (ja) * | 2004-03-18 | 2011-04-13 | レオ ファーマ アクティーゼルスカブ | ビタミンｄ類似体の立体選択的合成 |
| WO2006051106A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| EP1883626B1 (en) * | 2005-04-25 | 2017-10-11 | OPKO Ireland Global Holdings, Ltd. | Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3 |
| US20080051375A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same |
| US20080051380A1 (en) * | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
| WO2008024485A2 (en) | 2006-08-25 | 2008-02-28 | Cougar Biotechnology, Inc. | Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent |
| WO2008027532A2 (en) * | 2006-08-29 | 2008-03-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions including vitamin d and corticosteroid |
| EA026334B1 (ru) | 2009-01-27 | 2017-03-31 | БЕРГ ЭлЭлСи | Применение соединения витамина d для предотвращения или снижения развития химиотерапевтически индуцированной нейтропении |
| US20120184514A1 (en) * | 2009-07-01 | 2012-07-19 | Vitamin Derivatives Inc. | Vitamin d compounds and methods for preparing same |
| CN102655869B (zh) | 2009-08-14 | 2016-08-10 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
| CN112156097A (zh) | 2013-05-29 | 2021-01-01 | 博格有限责任公司 | 使用维生素d预防或减轻化疗诱发的脱发 |
| CA3031705A1 (en) | 2016-07-29 | 2018-02-01 | Janssen Pharmaceutica Nv | Treatment of prostate cancer with niraparib |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8914963D0 (en) | 1989-06-29 | 1989-08-23 | Leo Pharm Prod Ltd | Chemical compounds |
| US5260290A (en) * | 1990-02-14 | 1993-11-09 | Wisconsin Alumni Research Foundation | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives |
| GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| GB9206648D0 (en) * | 1992-03-26 | 1992-05-06 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9223061D0 (en) * | 1992-11-04 | 1992-12-16 | Leo Pharm Prod Ltd | Chemical compounds |
| US5449668A (en) * | 1993-06-04 | 1995-09-12 | Duphar International Research B.V. | Vitamin D compounds and method of preparing these compounds |
| US5552392A (en) | 1993-11-03 | 1996-09-03 | Wisconsin Alumni Research Foundation | Method of treating hypoparathyroidism with (20S) vitamin D compounds |
| JP3228488B2 (ja) * | 1993-12-24 | 2001-11-12 | 株式会社クラレ | ２０−エピステロイド誘導体およびその製造方法 |
| JPH0888281A (ja) * | 1994-09-19 | 1996-04-02 | Fujitsu Ltd | 半導体装置 |
| IL118156A (en) * | 1995-05-09 | 2001-08-26 | Duphar Int Res | Vitamin d compounds, their preparation and pharmaceutical compositions containing them |
-
1996
- 1996-10-30 GB GBGB9622590.9A patent/GB9622590D0/en active Pending
-
1997
- 1997-10-27 ES ES97910261T patent/ES2173425T3/es not_active Expired - Lifetime
- 1997-10-27 RU RU99111777/04A patent/RU2183622C2/ru active
- 1997-10-27 DE DE69712086T patent/DE69712086T2/de not_active Expired - Lifetime
- 1997-10-27 PT PT97910261T patent/PT937038E/pt unknown
- 1997-10-27 NZ NZ334328A patent/NZ334328A/xx not_active IP Right Cessation
- 1997-10-27 PL PL333068A patent/PL192660B1/pl unknown
- 1997-10-27 WO PCT/DK1997/000472 patent/WO1998018759A1/en active IP Right Grant
- 1997-10-27 AU AU47717/97A patent/AU722659B2/en not_active Expired
- 1997-10-27 CN CN97198407A patent/CN1107669C/zh not_active Expired - Lifetime
- 1997-10-27 EP EP97910261A patent/EP0937038B1/en not_active Expired - Lifetime
- 1997-10-27 US US09/297,387 patent/US6310226B1/en not_active Expired - Lifetime
- 1997-10-27 KR KR10-1999-7002315A patent/KR100526644B1/ko not_active IP Right Cessation
- 1997-10-27 CA CA002266479A patent/CA2266479C/en not_active Expired - Lifetime
- 1997-10-27 RO RO99-00325A patent/RO120338B1/ro unknown
- 1997-10-27 CZ CZ19991358A patent/CZ290933B6/cs not_active IP Right Cessation
- 1997-10-27 AT AT97910261T patent/ATE216361T1/de active
- 1997-10-27 DK DK97910261T patent/DK0937038T3/da active
- 1997-10-27 JP JP51993198A patent/JP3907010B2/ja not_active Expired - Lifetime
- 1997-10-27 HU HU9904333A patent/HUP9904333A3/hu unknown
-
2000
- 2000-02-29 HK HK00101222A patent/HK1022298A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0937038T3 (da) | 2002-07-15 |
| PL333068A1 (en) | 1999-11-08 |
| DE69712086D1 (de) | 2002-05-23 |
| JP2001503403A (ja) | 2001-03-13 |
| EP0937038B1 (en) | 2002-04-17 |
| HK1022298A1 (en) | 2000-08-04 |
| RU2183622C2 (ru) | 2002-06-20 |
| PT937038E (pt) | 2002-09-30 |
| DE69712086T2 (de) | 2002-11-14 |
| CN1107669C (zh) | 2003-05-07 |
| GB9622590D0 (en) | 1997-01-08 |
| ATE216361T1 (de) | 2002-05-15 |
| EP0937038A1 (en) | 1999-08-25 |
| HUP9904333A2 (hu) | 2000-06-28 |
| CA2266479A1 (en) | 1998-05-07 |
| CZ290933B6 (cs) | 2002-11-13 |
| RO120338B1 (ro) | 2005-12-30 |
| KR20000036233A (ko) | 2000-06-26 |
| NZ334328A (en) | 2000-09-29 |
| HUP9904333A3 (en) | 2001-06-28 |
| US6310226B1 (en) | 2001-10-30 |
| CN1232448A (zh) | 1999-10-20 |
| CA2266479C (en) | 2008-09-23 |
| KR100526644B1 (ko) | 2005-11-08 |
| AU722659B2 (en) | 2000-08-10 |
| CZ135899A3 (cs) | 1999-07-14 |
| AU4771797A (en) | 1998-05-22 |
| JP3907010B2 (ja) | 2007-04-18 |
| PL192660B1 (pl) | 2006-11-30 |
| WO1998018759A1 (en) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2173425T3 (es) | Analogos de la vitamina d | |
| ES2189476T3 (es) | Odorizado de gases. | |
| AR000929A1 (es) | Compuestos herbicidas de bencisoxazol y bencisotiazol substituido, composicion que los comprende y metodos para controlar con los mismos especiesde plantas indeseables. | |
| BR0300968A (pt) | Misturas estabilizadoras | |
| BR9709427A (pt) | Oxa ácidos e compostos relacionados para tratamento de condições da pele | |
| AR015740A1 (es) | CETOENOLES CíCLICOS ARILFENIL-SUBSTITUIDOS, PROCEDIMIENTO PARA SU OBTENCIoN , COMPUESTOS uTILES PARA PREPARAR DICHOS CETOENOLES, COMPOSICIONES PESTICIDAS, Y /O HERBICIDAS,EMPLEO DE DICHOS CETOENOLES,MÉTODO PARA CONTROLAR LAS PESTES, Y , MÉTODO PARA LA PREPARACIoN DE DICHAS COMPOSICIONES PESTICIDAS Y | |
| BR0215052A (pt) | Composições acaricidas e métodos | |
| PE46497A1 (es) | ANTAGONISTAS a1-ADRENOCEPTORES, SUS EMPLEOS COMO AGENTES TERAPEUTICOS Y LOS METODOS DE SU PREPARACION | |
| ES2160237T3 (es) | O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos. | |
| ES2195577T3 (es) | Derivados de epotilon, procedimiento para su preparacion y su utilizacion. | |
| ES2179996T3 (es) | Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos. | |
| ES2181766T3 (es) | Analogos de delda 12,13-isotaxol, uso antineoplasico y composiciones farmaceuticas que los contienen. | |
| BR0316576A (pt) | Método cosmético para o clareamento da pele e composição cosmética | |
| EA200200098A1 (ru) | Ароматические сложные эфиры для маркировки или мечения нефтепродуктов | |
| ES2164340T3 (es) | Agentes y procedimiento para la lucha contra los hongos dañinos. | |
| AR007005A1 (es) | Composiciones repelentes de artropodos y procedimiento para repeler artropodos | |
| GT200000049A (es) | Compuestos quimicos. | |
| FI951134A (fi) | Fluorattu D3-vitamiinijohdannainen | |
| ES2148816T3 (es) | Analogo de vitamina d. | |
| MX168469B (es) | Procedimiento para la preparacion de derivados aminoalcoholes acilados | |
| MX9203567A (es) | Derivado de monocolin, procedimiento para su preparacion y medicamento que contiene este derivado. | |
| ES2190222T3 (es) | Derivados de 3-(2-oxo-(1,3')bipirrolindinil-3-iliden-metil)-cefem. | |
| ES2180972T3 (es) | Composicion contra el helicobacter pilori que contiene derivados de 1-metilcarbapenem como ingrediente activo. | |
| MX9303863A (es) | 2-4-dialquil-6-alquilfenoles secundarios. | |
| BR0315647A (pt) | Novos compostos para composições de tingimento de cabelos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 937038 Country of ref document: ES |